Skip to content
Trial Eligibility
Menu

Impact of Prophylactic Ephedrine on Fetal Heart Tracing and Uterine Tetanic Contraction After CSE

NCT05873218

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Labor analgesia is an important component of the care of laboring patients. A known side effect of combined spinal and epidural anesthesia (a type of labor analgesia) is an increased incidence of category II fetal heart rate tracing (defined below) and low blood pressure. The study team aims to study if a prophylactic dose of ephedrine will decrease the occurrence of this type of tracing after combined spinal epidural (CSE) anesthesia placement. Ephedrine is not currently routinely used as prevention for category II tracings or low blood pressure.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Labor

Eligibility basics and study details

Study type
Interventional
Phase
Phase 4
Ages
18 to 55 years
Sex
Female
Healthy volunteers
Accepted
Sponsor
Icahn School of Medicine at Mount Sinai
Last updated on ClinicalTrials.gov
May 6, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • Icahn School of Medicine at Mount SInai · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.